NNNS: Weight (2006)
Citation:
Study Design:
Class:
- Click here for explanation of classification scheme.
Quality Rating:
Research Purpose:
To review the literature regarding the effect of sweetness on appetite control as it relates to overconsumption and weight maintenance.
Inclusion Criteria:
Not described.
Exclusion Criteria:
Not described.
Description of Study Protocol:
Review of selected literature.
Data Collection Summary:
Description of Actual Data Sample:
Summary of Results:
- Porikos et al: Found that lean and obese participants living in a metabolic ward ate fewer calories during a six- or 12-day period, when investigators covertly replaced all sucrose with aspartame in an ad libitum diet, compared with when they were fed a high-sucrose diet.
- Tordoff and Alleva: Reported that consuming aspartame-sweetened soda significantly reduced energy intake in males (1,183kJ per day) and females (987kJ per day), eating their normal diet and significantly decreased the body weight of males over a three-week period, when compared with a no-drink condition.
- Kanders et al: Recruited 59 obese (37kg/m2) men and women to participate in a 12-week multi-disciplinary diet program. Participants were randomly assigned to consume a balanced-deficit diet (1,000±200kcal per day) with or without aspartame. At the end of the 12-week period, women (N=46) lost slightly more weight (7.4 vs 5.8kg) when they supplemented a hypocaloric diet with aspartame-containing foods and beverages. Men (N=13)≤ however showed the opposite trend (10.4 vs. 12.2kg).
Forty six of these subjects (11 males and 35 females) participated in the one-year follow-up evaluation. Participants selected whether to use or not use aspartame. Over the one-year follow-up, aspartame intake decreased in the aspartame group and increased in the no-aspartame group. Factors associated with maintenance of weight loss at one-year of follow-up included increased physical activity levels, increased aspartame consumption and decreased desire for sweets. - Blackburn et al: Conducted a randomized controlled, prospective outpatient clinical trial investigating whether the addition of aspartame to a multi-disciplinary weight program would improve weight loss and long-term control of body weight in obese women. 163 obese women were randomly assigned to consume or to abstain from aspartame-sweetened foods and beverages during 16 weeks of a 19-week weight reduction program, a one-year maintenance program and a two-year follow-up program. Women in both treatment groups lost 10% of initial body weight (10kg) during active weight loss. Among women assigned to the aspartame group, aspartame was positively correlated with percentage of weight lost (R=0.32; P<0.01). During maintenance, the aspartame group experienced a 2.6% (2.6kg) regain in initial body weight, while those in the no-aspartame group gained an average of 5.4% (5.4 kg). The aspartame group lost significantly less weight during maintenance than did the no-aspartame group (P=0.046). Percentage of weight lost during the 71-week study was postively correlated with exercise (R=0.32; P<0.001) and self-reported eating control (R=0.37; P<0.001).
Author Conclusion:
- Low-calorie sweeteners can provide palatability and satisfy hedonic urges without adding calories, and may facilitate control of body weight in motivated individuals.
- Results from outpatient clinical trials suggest that increased aspartame intake is associated with either decreased or unchanged ratings of hunger and desire for sweets and that participation in a multi-disciplinary weight-control program that includes aspartame may facilitate the long-term maintenance of a reduced body weight.
Funding Source:
University/Hospital: | Beth Israel Deaconess Medical Center, Harvard Medical School |
Reviewer Comments:
- This was a discussion of selected literature.
- There was no indication that a lit search was conducted to identify the complete body of literature related to the topics presented.
Quality Criteria Checklist: Review Articles
|
|||
Relevance Questions | |||
1. | Will the answer if true, have a direct bearing on the health of patients? | Yes | |
1. | Will the answer if true, have a direct bearing on the health of patients? | Yes | |
2. | Is the outcome or topic something that patients/clients/population groups would care about? | Yes | |
2. | Is the outcome or topic something that patients/clients/population groups would care about? | Yes | |
3. | Is the problem addressed in the review one that is relevant to dietetics practice? | Yes | |
3. | Is the problem addressed in the review one that is relevant to dietetics practice? | Yes | |
4. | Will the information, if true, require a change in practice? | Yes | |
4. | Will the information, if true, require a change in practice? | Yes | |
Validity Questions | |||
1. | Was the question for the review clearly focused and appropriate? | Yes | |
1. | Was the question for the review clearly focused and appropriate? | Yes | |
2. | Was the search strategy used to locate relevant studies comprehensive? Were the databases searched and the search termsused described? | No | |
2. | Was the search strategy used to locate relevant studies comprehensive? Were the databases searched and the search termsused described? | No | |
3. | Were explicit methods used to select studies to include in the review? Were inclusion/exclusion criteria specified andappropriate? Wereselectionmethods unbiased? | No | |
3. | Were explicit methods used to select studies to include in the review? Were inclusion/exclusion criteria specified andappropriate? Wereselectionmethods unbiased? | No | |
4. | Was there an appraisal of the quality and validity of studies included in the review? Were appraisal methodsspecified,appropriate, andreproducible? | No | |
4. | Was there an appraisal of the quality and validity of studies included in the review? Were appraisal methodsspecified,appropriate, andreproducible? | No | |
5. | Were specific treatments/interventions/exposures described? Were treatments similar enough to be combined? | No | |
5. | Were specific treatments/interventions/exposures described? Were treatments similar enough to be combined? | No | |
6. | Was the outcome of interest clearly indicated? Were other potential harms and benefits considered? | Yes | |
6. | Was the outcome of interest clearly indicated? Were other potential harms and benefits considered? | Yes | |
7. | Were processes for data abstraction, synthesis, and analysis described? Were they applied consistently acrossstudies and groups? Was thereappropriate use of qualitative and/or quantitative synthesis? Was variation in findings among studies analyzed? Were heterogeneity issued considered? If data from studies were aggregated for meta-analysis, was the procedure described? | No | |
7. | Were processes for data abstraction, synthesis, and analysis described? Were they applied consistently acrossstudies and groups? Was thereappropriate use of qualitative and/or quantitative synthesis? Was variation in findings among studies analyzed? Were heterogeneity issued considered? If data from studies were aggregated for meta-analysis, was the procedure described? | No | |
8. | Are the results clearly presented in narrative and/or quantitative terms? If summary statistics are used, are levels ofsignificance and/or confidence intervals included? | Yes | |
8. | Are the results clearly presented in narrative and/or quantitative terms? If summary statistics are used, are levels ofsignificance and/or confidence intervals included? | Yes | |
9. | Are conclusions supported by results with biases and limitations taken into consideration? Are limitations ofthe review identified anddiscussed? | Yes | |
9. | Are conclusions supported by results with biases and limitations taken into consideration? Are limitations ofthe review identified anddiscussed? | Yes | |
10. | Was bias due to the review's funding or sponsorship unlikely? | Yes | |
10. | Was bias due to the review's funding or sponsorship unlikely? | Yes | |